Labetalol
Labetalol, a combined alpha- and beta-adrenergic blocker, is employed in managing hypertension both orally for chronic control and intravenously for emergencies, with its metabolism impacted by CYP2C19 genetic variations. It serves as a key tool in cardiovascular research for in vitro receptor binding assays and in vivo models of hypertensive disease.
Product Specifications
CAS Number
36894-69-6
Product Name Alternative
Apo-Labetalol, AH5158, AH-5158, AH 5158, AdrenergicReceptor, Adrenergic Receptor, Albetol, Dilevalol, guinea pig, hypertension in pregnancy, Labetalol, Normodyne, Trandate, Sch-15719W, selective, blood-brain barrier
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.87% (May vary between batches)
Solubility
DMSO:137.5 mg/mL (418.68 mM)
Smiles
CC (CCc1ccccc1) NCC (O) c1ccc (O) c (c1) C (N) =O
Molecular Formula
C19H24N2O3
Molecular Weight
328.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC219171L4V 200 µL
Transcription termination factor 1 (TTF1) (NM_007344) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 